Precision Medicine
Novartis Invests $1 Billion in Acquisition of Radioligand Therapy Pioneer Mariana
Novartis, Mariana, radioligand therapy, cancer treatment, targeted therapy, precision medicine, billion-dollar acquisition, healthcare innovation.
BridgeBio Launches KRAS-Targeted Cancer Startup with $200 Million in Venture Capital Funding
BridgeBio, KRAS, cancer, startup, venture capital, funding, newco, oncology, precision medicine, targeted therapies.
BMS Collaborates to Revolutionize Immunotherapy: The Repertoire Vaccine Partnership
BMS, Bristol-Myers Squibb, Repertoire, immunotherapy, vaccine, immune system reset, partnership, cancer treatment, personalized medicine.